Suppr超能文献

嗜黏蛋白阿克曼氏菌外膜蛋白通过JAK-STAT信号通路调节肺腺癌中CD8 T细胞的募集。

Akkermansia muciniphila outer membrane protein regulates recruitment of CD8 T cells in lung adenocarcinoma and through JAK-STAT signalling pathway.

作者信息

Xu Yufen, Tan Xiaoli, Yang Qi, Fang Zhixian, Chen Wenyu

机构信息

Department of Oncology, The Affiliated Hospital of Jiaxing University, Jiaxing City, China.

Department of Respiratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing City, China.

出版信息

Microb Biotechnol. 2024 Jul;17(7):e14522. doi: 10.1111/1751-7915.14522.

Abstract

As a Gram-negative anaerobic bacterium, Akkermansia muciniphila (AKK) participates in the immune response in many cancers. Our study focused on the factors and molecular mechanisms of AKK affecting immune escape in lung adenocarcinoma (LUAD). We cultured AKK bacteria, prepared AKK outer membrane protein Amuc_1100 and constructed a subcutaneous graft tumour mouse model. A549, NCI-H1395 cells and mice were respectively treated with inactivated AKK, Amuc_1100, Ruxolitinib (JAK inhibitor) and RO8191 (JAK activator). CD8 T cells that penetrated the membrane were counted in the Transwell assay. The toxicity of CD8 T cells was evaluated by lactate dehydrogenase assay. Western blot was applied to determine JAK/STAT-related protein and PD-L1 expression, whilst CCL5, granzyme B and INF-γ expression were assessed through enzyme-linked immunosorbent assay (ELISA). The proportion of tumour-infiltrating CD8 T cells and the levels of granzyme B and INF-γ were determined by flow cytometry. AKK markedly accelerated A549 and NCI-H1395 recruiting CD8 T cells and enhanced CD8 T cell toxicity. Amuc_1100 purified from AKK exerted the same promoting effects. Besides, Amuc_1100 dramatically suppressed PD-L1, p-STAT and p-JAK expression and enhanced CCL5, granzyme B and INF-γ expression. Treatment with Ruxolitinib accelerated A549 and NCI-H1395 cells recruiting CD8 T cells, enhanced CD8 T cell toxicity, CCL5, granzyme B and INF-γ expression, and inhibited PD-L1 expression. In contrast, the RO8191 treatment slowed down the changes induced by Amuc_1100. Animal experiments showed that Amuc_1100 was found to increase the number of tumour-infiltrating CD8 T cells, increase the levels of granzyme B and INF-γ and significantly inhibit the expression of PD-L1, p-STAT and p-JAK, which exerted an antitumour effect in vivo. In conclusion, through inhibiting the JAK/STAT signalling pathway, AKK outer membrane protein facilitated the recruitment of CD8 T cells in LUAD and suppressed the immune escape of cells.

摘要

作为一种革兰氏阴性厌氧菌,嗜黏蛋白阿克曼氏菌(AKK)参与多种癌症的免疫反应。我们的研究聚焦于AKK影响肺腺癌(LUAD)免疫逃逸的因素及分子机制。我们培养了AKK细菌,制备了AKK外膜蛋白Amuc_1100,并构建了皮下移植瘤小鼠模型。分别用灭活的AKK、Amuc_1100、鲁索替尼(JAK抑制剂)和RO8191(JAK激活剂)处理A549、NCI-H1395细胞和小鼠。在Transwell实验中计数穿透膜的CD8 T细胞。通过乳酸脱氢酶测定评估CD8 T细胞的毒性。应用蛋白质免疫印迹法测定JAK/STAT相关蛋白和PD-L1表达,同时通过酶联免疫吸附测定(ELISA)评估CCL5、颗粒酶B和INF-γ表达。通过流式细胞术测定肿瘤浸润CD8 T细胞的比例以及颗粒酶B和INF-γ的水平。AKK显著加速A549和NCI-H1395募集CD8 T细胞并增强CD8 T细胞毒性。从AKK中纯化的Amuc_1100发挥相同的促进作用。此外,Amuc_1100显著抑制PD-L1、p-STAT和p-JAK表达并增强CCL5、颗粒酶B和INF-γ表达。用鲁索替尼处理加速A549和NCI-H1395细胞募集CD8 T细胞,增强CD8 T细胞毒性、CCL5、颗粒酶B和INF-γ表达,并抑制PD-L1表达。相反,RO8191处理减缓了Amuc_1100诱导的变化。动物实验表明,发现Amuc_1100增加肿瘤浸润CD8 T细胞数量,提高颗粒酶B和INF-γ水平并显著抑制PD-L1、p-STAT和p-JAK的表达,在体内发挥抗肿瘤作用。总之,通过抑制JAK/STAT信号通路,AKK外膜蛋白促进LUAD中CD8 T细胞的募集并抑制细胞的免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9a/11253302/bb1ac5c96d90/MBT2-17-e14522-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验